Tuesday, July 7, 2015

Enriched blood cells preserve cognition in mice with features of Alzheimer's disease

Enriched blood cells preserve cognition in mice with features of Alzheimer's disease: Cedars-Sinai researchers have successfully tested two new methods for preserving cognition in laboratory mice that exhibit features of Alzheimer's disease by using white blood cells from bone marrow and a drug for multiple sclerosis to control immune response in the brain.

Wednesday, June 24, 2015

Is Alzheimer's disease preventable? - CNN.com

Is Alzheimer's disease preventable? - CNN.com: That is why the Alzheimer's Association created a list of 10 things that are good for your brain and good for your health. It's possible these are also beneficial at slowing or preventing Alzheimer's or related dementia. Tips include getting enough sleep, eating healthy, exercising a few times a week and not smoking. They also encourage enrollment in a clinical trial. The association website can help direct and connect people with research going on in their area.

Wednesday, June 3, 2015

UC Berkeley researcher leads study linking poor sleep to Alzheimer's disease | The Daily Californian

UC Berkeley researcher leads study linking poor sleep to Alzheimer's disease | The Daily Californian: A team of scientists led by a UC Berkeley researcher has linked persistent poor sleep to the buildup of a toxic protein that can inhibit the ability to form long-term memory and, eventually, lead to the onset of Alzheimer’s disease.

A study published Monday by a group led by Bryce Mander, a postdoctoral fellow in the UC Berkeley psychology department, describes how low-quality, disturbed sleep leads to the buildup of the toxic protein beta-amyloid. The study was published online in the journal Nature Neuroscience.

Tuesday, May 26, 2015

Diabetes Speeds up Progression of Alzheimer’s Disease by up to 40 Percent : News : Headlines & Global News

Diabetes Speeds up Progression of Alzheimer’s Disease by up to 40 Percent : News : Headlines & Global News: Diabetes might be a significant risk factor for developing Alzheimer's disease and other forms of dementia, and could speed up the process of developing the neurological conditions by up to 40 percent.

Wednesday, April 29, 2015

Scientists discover protective molecule against Alzheimer's Disease

Scientists discover protective molecule against Alzheimer's Disease: The research is part of a joint collaboration between groups of scientists led by Professor Xin-Fu Zhou from the University of South Australia and Professor Yanjiang Wang at China's Third Military University.

Earlier this month the research partnership discovered a drug used in the treatment of stroke victims could help stop the progression of the disease.

The scientists have made a discovery of one of the mechanisms of Alzheimer's Disease.

Saturday, April 18, 2015

Arginine May Be A Cause and Therapeutic Target for Alzheimer’s Disease in Mice Alzheimer's News Today

Arginine May Be A Cause and Therapeutic Target for Alzheimer’s Disease in Mice Alzheimer's News Today: A new study published in the Journal of Neuroscience revealed that specific immune cells and degradation of a nutrient called arginine might be linked to Alzheimer’s disease development. The study was performed by researchers at Duke University Medical Center, the West Virginia University School of Medicine and the University of Washington, and is entitled “Arginine Deprivation and Immune Suppression in a Mouse Model of Alzheimer’s Disease.”

Tuesday, March 24, 2015

Alzheimer's disease cured in mice with ultrasound technology - GeekSnack

Alzheimer's disease cured in mice with ultrasound technology - GeekSnack: Alzheimer’s disease affects 50 million people worldwide. By definition it is the most common form of dementia, which causes memory loss, problems with thinking and behavior. Symptoms develop slowly and get worse as the patient gets older. Majority of people with Alzheimer’s are 65 and older, yet it can develop from the earlier age of 40s or 50s. In the initial stages people start losing their memory, and as it progresses individuals lose their ability to perform daily tasks, not being able to communicate or remember anything about their surroundings.

Tuesday, March 17, 2015

New MIND diet may significantly protect against Alzheimer's disease

New MIND diet may significantly protect against Alzheimer's disease: A new diet, appropriately known by the acronym MIND, could significantly lower a person's risk of developing Alzheimer's disease, even if the diet is not meticulously followed, according to a paper published online for subscribers in March in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

Friday, March 13, 2015

Ultrasound therapies target brain cancers and Alzheimer’s disease | Science/AAAS | News

Ultrasound therapies target brain cancers and Alzheimer’s disease | Science/AAAS | News: From imaging babies to blasting apart kidney stones, ultrasound has proved to be a versatile tool for physicians. Now, several research teams aim to unleash the technology on some of the most feared brain diseases.

The blood-brain barrier, a tightly packed layer of cells that lines the brain's blood vessels, protects it from infections, toxins, and other threats but makes the organ frustratingly hard to treat. A strategy that combines ultrasound with microscopic blood-borne bubbles can briefly open the barrier, in theory giving drugs or the immune system access to the brain. In the clinic and the lab, that promise is being evaluated.

Saturday, January 24, 2015

Nasal spray shows promise as treatment for Alzheimer's disease

Nasal spray shows promise as treatment for Alzheimer's disease | Fox News: Researchers say they’ve developed a nasal spray that could potentially improve memory and other mental capabilities for the more than 5 million Americans suffering from Alzheimer’s disease.

In a pilot study at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, researchers studied 60 adults between the ages of 55 and 85 diagnosed with mild cognitive impairment (MCI) or mild to moderate Alzheimer's dementia (AD). Participants were nasally administered doses of man-made insulin called insulin detemir for 21 days.